ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,488,749 | +122.3% | 2,929,818 | +129.2% | 0.00% | +50.0% |
| Q2 2023 | $4,717,240 | +2466.4% | 1,278,385 | +2202.1% | 0.00% | – |
| Q1 2023 | $183,807 | +85391.6% | 55,531 | 0.0% | 0.00% | – |
| Q4 2022 | $215 | -99.8% | 55,531 | -4.6% | 0.00% | – |
| Q3 2022 | $141,000 | +11.9% | 58,179 | -9.0% | 0.00% | – |
| Q2 2022 | $126,000 | +18.9% | 63,962 | +10.9% | 0.00% | – |
| Q1 2022 | $106,000 | +30.9% | 57,672 | 0.0% | 0.00% | – |
| Q4 2021 | $81,000 | -30.8% | 57,672 | -44.1% | 0.00% | – |
| Q3 2021 | $117,000 | -47.5% | 103,218 | -25.9% | 0.00% | – |
| Q2 2021 | $223,000 | -16.5% | 139,313 | -8.2% | 0.00% | – |
| Q1 2021 | $267,000 | +853.6% | 151,713 | +1181.4% | 0.00% | – |
| Q3 2020 | $28,000 | -48.1% | 11,840 | -16.2% | 0.00% | – |
| Q1 2019 | $54,000 | +58.8% | 14,127 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | – | 14,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |